The ACR Committee on Training and Workforce is pleased to present the Virtual Rheumatology Teaching Lessons – Adult (ViTLs). This interactive series takes a deep dive into specific topics targeted to fellows in adult rheumatology fellowship programs. Initially launched in 2021, this monthly lecture series is led by professionals across the U.S. who are known for their expertise and exceptional educational experiences.
2023 ViTLs Preliminary Program
Times and speakers are subject to change. Recordings will be available within 24 hours after the live session.
Watch ViTLs Adult Playlist
Register for 2023 ViTLs
This program is designed for educational purposes only. The material presented is not intended to represent the only or the best methods appropriate for the medical situations discussed, but rather is intended to present the opinions of the authors or presenters, which may be helpful to other practitioners. Attendees participating in this education activity sponsored by the ACR do so with full knowledge that they waive any claim they may have against the ACR for reliance on any information presented during this educational activity.
Race, Ethnicity and RheumatologyBecki Cleveland, MDVirginia Steen, MDRichard Lee, MD
In this session, topics on race, ethnicity, and rheumatology will be covered by three speakers:
Watch ViTLs Adult Playlist
Mimics: Scleroderma / Vasculitis / SpondyloarthropathyMarcy Bolster, MDLaura Hummers, MD, MSMatthew Koster, MDDavid Borenstein, MD, MACR, MACP
In this session, Laura Hummers, MD, MS, uses a case-based format to review the differential diagnosis of thickened skin, highlighting key clinical ways to differentiate scleroderma from scleroderma mimics. In their case-based presentations, Matthew J. Koster, MD, discusses three vasculitis mimics and provides guidance on how to effectively use details in the history, exam, imaging and ancillary studies to successfully differentiate between these mimics and true vasculitis. David Borenstein, MD, MACR, MACP, discusses the characteristic changes noted in the lumbar spine and sacroiliac joints that differentiate ankylosing spondylitis from other spinal disorders that cause abnormal calcification of these structures.
Macrophage Activation Syndrome / HLHTyler Reese, MDMcKenzie Rose Vater, MDAlexei Grom, MDMichelle Hermiston, MD, PhD
In the presentation, Macrophage Activation Syndrome – Early Recognition and Therapeutic Targets, Alexei Grom, MD, discusses initial diagnostic evaluation, pathophysiology and emerging therapeutic targets in macrophage activation syndrome. In the presentation, Diagnostic and Therapeutic Approach to HLH/MAS, Michelle Hermiston, MD, PhD, uses a case-based approach to discuss a systematic approach to the evaluation and management of a patient with suspected macrophage activation syndrome (MAS)/hemophagocytic lymphohistiocytosis (HLH).
EGPAAnish Dua, MD, MPHPhilip Seo, MD, MHSMike Wechsler, MD, MMScFei Li Kuang, MD, MPH
Mike Wechsler, MD, MMSc, focuses on the functions and roles of eosinophils and the treatment strategies for hypereosinophilic conditions.Fei Li Kuang, MD, PhD, highlights and discusses the similarities and differences in the diagnoses of EGPA and HES, and why that matters, especially in an era where targeted anti-eosinophil therapies are available.
Psoriatic ArthritisLianne Gensler, MDElaine Husni, MD, MPHGurjit Kaely, MBBS, MRCP
In this session, Elaine Husni, MD, MPH, reviews the clinical presentation, management strategies, and treatment options for psoriatic arthritis, as well as an emphasis on how the disease affects the patient. In addition, Gurjit Kaeley, MRCP, RhMSUS, reviews the clinical utility and sonographic features of psoriatic arthritis, including the domains of enthesitis, dactylitis, and psoriatic joint disease.
SarcoidosisNadera Sweiss, MDPrashant Parmar, MDOmar F. Abou-Ezzeddine, MD, CM, MSPooja Bhat, MD
Nadera Sweiss, MD, and Prashant Parmar, MD, provide an overview of the management and treatment of sarcoidosis. The session also includes presentations on both sarcoid heart disease and ocular sarcoidosis by Omar F. Abou-Ezzeddine, MD, CM, MS, and Pooja Bhat, MD, respectively.
Watch ViTLs Adult Playlist
COVID-19 and RheumatologyJean Liew, MDErin Wilfong, MD, PhDMehrdad Matloubian, MD, PhD
This session discusses the management of the rheumatology patient diagnosed with COVID-19 and will cover COVID-19 complications, medication effects on vaccine response, and the relationship between vaccine response and underlying rheumatologic disease.
Lupus Disparities and Reproductive Justice in LupusSusan Manzi, MD, MPHMegan E. B. Clowse, MD, MPH
This session covers the role of health disparities as it relates to the diagnosis and management of patients with lupus and describes the clinical features as well as social features that impact pregnancy in lupus.
Dermatomyositis: Bridging Dermatology and RheumatologyLisa Christopher-Stine, MD, MPHVictoria P. Werth, MD, MS
In this case-based presentation, Dr. Lisa Christopher-Stine and Dr. Victoria Werth discuss the collaborative dermatologic/rheumatologic approach to the diagnosis and treatment of dermatomyositis. They examine organ system involvement – involving skin, muscle, joint, etc., from 2 clinician specialty viewpoints. They review unique clinical findings as well as their histopathological and immunopathological correlates and apply this collaborative approach to the management of dermatologic and rheumatologic features in patients with dermatomyositis.
ANCA VasculitisGeetha Duvuru, MDAlexandra Villa Forte, MD, MPH
In this session, Drs. Villa Forte and Duvuru debate the role of PLEX in remission induction and choosing between rituximab and cyclophosphamide for remission induction. They also review therapy choices for remission maintenance and role of ANCA and CD 19 monitoring for guiding remission maintenance therapy.
Inflammatory Eye Disease for the RheumatologistLaura Kopplin, MD, PhDBryn Burkholder, MDJim Rosenbaum, MD
This session reviews three common forms of inflammatory eye disease seen in patients with rheumatic conditions (scleritis, uveitis, and orbital inflammatory disease), and provides an overview of common clinical findings, mimickers, and suggestions for evaluation and treatment.
Interstitial Lung Disease Associated with Systemic Rheumatic DiseasesKristin B. Highland, MD, MSCR
In this case-based presentation, Kristin B. Highland, MD, MSCR, discusses initial evaluations, approaches to treatment, and monitoring of patients with interstitial lung disease (ILD) associated with systemic rheumatic diseases.